"Rabeprazole" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A 4-(3-methoxypropoxy)-3-methylpyridinyl derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS.
| Descriptor ID |
D064750
|
| MeSH Number(s) |
D02.886.640.074.750 D03.383.725.024.750 D03.633.100.103.034.750
|
| Concept/Terms |
Rabeprazole- Rabeprazole
- 2-((4-(3-methoxypropoxy)-3-methylpyridin-2-yl)methylsulfinyl)-1H-benzimidazole
Rabeprazole Sodium- Rabeprazole Sodium
- Sodium, Rabeprazole
- 1H-Benzimidazole, 2-(((4-(3-methoxypropoxy)-3-methyl-2-pyridinyl)methyl)sulfinyl)-, Sodium Salt
|
Below are MeSH descriptors whose meaning is more general than "Rabeprazole".
Below are MeSH descriptors whose meaning is more specific than "Rabeprazole".
This graph shows the total number of publications written about "Rabeprazole" by people in this website by year, and whether "Rabeprazole" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2002 | 0 | 1 | 1 |
| 2005 | 0 | 1 | 1 |
| 2006 | 0 | 1 | 1 |
| 2009 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Rabeprazole" by people in Profiles.
-
The effect of acid suppression on upper airway anatomy and obstruction in patients with sleep apnea and gastroesophageal reflux disease. J Clin Sleep Med. 2009 Aug 15; 5(4):330-4.
-
Effect of esophageal acid and prophylactic rabeprazole on performance in runners. Med Sci Sports Exerc. 2006 Sep; 38(9):1659-65.
-
The effect of acid suppression on sleep patterns and sleep-related gastro-oesophageal reflux. Aliment Pharmacol Ther. 2005 Jan 15; 21(2):103-8.
-
Rabeprazole in nonerosive gastroesophageal reflux disease: a randomized placebo-controlled trial. Am J Gastroenterol. 2002 Jun; 97(6):1332-9.
-
Onset of symptom relief with rabeprazole: a community-based, open-label assessment of patients with erosive oesophagitis. Aliment Pharmacol Ther. 2002 Mar; 16(3):445-54.